These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 23940388

  • 1. The promise of pharmacoepidemiology in helping clinicians assess drug risk.
    Avorn J.
    Circulation; 2013 Aug 13; 128(7):745-8. PubMed ID: 23940388
    [No Abstract] [Full Text] [Related]

  • 2. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
    Berman JP, Halperin JL.
    Hosp Pract (1995); 2013 Feb 13; 41(1):37-48. PubMed ID: 23466966
    [Abstract] [Full Text] [Related]

  • 3. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
    Steurer J.
    Praxis (Bern 1994); 2014 Aug 20; 103(17):1032. PubMed ID: 25146949
    [No Abstract] [Full Text] [Related]

  • 4. [Atrial fibrillation: what the GP needs to know].
    Diener HC, Kaeufer T, Bode C.
    MMW Fortschr Med; 2011 Sep 22; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract] [Full Text] [Related]

  • 5. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
    Kosar L, Jin M, Kamrul R, Schuster B.
    Can Fam Physician; 2012 Aug 22; 58(8):850-8. PubMed ID: 22893338
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
    Kasmeridis C, Lip GY, Apostolakis S.
    Hosp Pract (1995); 2013 Feb 22; 41(1):61-70. PubMed ID: 23466968
    [Abstract] [Full Text] [Related]

  • 8. [Clinical management of the new anticoagulants].
    Zapata Wainberg G, Ximénez-Carrillo Rico A, Vivancos Mora J.
    Neurologia; 2012 Mar 22; 27 Suppl 1():33-8. PubMed ID: 22682208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Differential therapy with the new anticoagulants, 5].
    Stiefelhagen P.
    MMW Fortschr Med; 2013 May 16; 155(9):20. PubMed ID: 23951642
    [No Abstract] [Full Text] [Related]

  • 12. [Gastrointestinal bleeding under treatment with new oral anticoagulants].
    Konturek P, Hess T.
    MMW Fortschr Med; 2014 Feb 06; 156(2):50-2. PubMed ID: 24934056
    [No Abstract] [Full Text] [Related]

  • 13. [Stroke risk--atrial fibrillation].
    Dabitz R, Ochs G.
    MMW Fortschr Med; 2012 Nov 01; 154(19):53-6. PubMed ID: 23173288
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y, Lip GY.
    Contrib Nephrol; 2013 Nov 01; 179():81-91. PubMed ID: 23652451
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
    Stöllberger C, Finsterer J.
    Thromb Haemost; 2013 Sep 01; 110(3):496-500. PubMed ID: 23803875
    [No Abstract] [Full Text] [Related]

  • 20. Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
    Diener HC.
    Thromb Haemost; 2013 Sep 01; 110(3):493-5. PubMed ID: 23803957
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.